US Broker Ratings

Replimune Group, Inc. (REPL) Stock Analysis: Understanding the Potential in Oncolytic Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL) stands at the forefront of innovation in the biotechnology sector, with a focus on developing and commercializing oncolytic immunotherapies to combat cancer. Headquartered in Woburn,..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenging Waters with Potential for Future Growth

Surmodics, Inc. (SRDX), a key player in the healthcare sector, specializes in performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic tests. Based..

AMN Healthcare Services Inc (AMN): Investor Outlook with 8.65% Upside Potential

AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, stands as a vital player in the medical care facilities industry in the United States. With a..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a Potential 186% Upside in Biotechnology

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its robust development pipeline aimed at tackling various cancers. With a market capitalization..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 3,585.87% Upside in Biotechnology

Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, has captured the attention of investors with a staggering potential upside of 3,585.87%. This potential is reflected in the analyst target price range,..

Ginkgo Bioworks Holdings, Inc. (DNA): Stock Analysis Reveals -19.90% Potential Downside Amidst Biotech Challenges

Ginkgo Bioworks Holdings, Inc. (DNA), a pioneering entity in the biotechnology sector, is at a critical juncture with its innovative approach to cell programming and biosecurity. Headquartered in Boston, Massachusetts,..

Geron Corporation (GERN) Stock Analysis: A Biotech Gem with 150% Potential Upside

For investors with an eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a market capitalization of approximately $925.12 million, this California-based biopharmaceutical company specializes..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 59.5% Potential Upside in the Biotechnology Arena

Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the biotechnology sector with its focus on developing innovative therapeutics for disorders related to dysfunctional signaling of the transforming growth factor-beta family..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Innovator with Nearly 95% Upside Potential

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, operates within the rapidly expanding field of health information services. With a market capitalization of approximately $312.95 million, LifeMD..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 124.59% Potential Upside in the Medical Device Sector

In the burgeoning field of medical devices, Butterfly Network, Inc. (NASDAQ: BFLY) stands out with its innovative approach to ultrasound imaging solutions. Despite the challenges faced in the healthcare sector,..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating an 85% Upside Potential

Neuropace, Inc. (NPCE), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its innovative contributions to the treatment of drug-resistant focal..

Investors Eye STAAR Surgical (STAA) Amid 55% Revenue Decline and High Forward P/E

STAAR Surgical Company (NASDAQ: STAA) has been a prominent name in the medical instruments and supplies industry for decades, with its innovative implantable lenses and laser-based procedures catering to a..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 55% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with a potential upside of 55.32%, according to recent analyst ratings. As a clinical-stage biopharmaceutical company, Arbutus is..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 88% Upside in Biotech Innovation

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing the attention of investors with its innovative approach to immunology-based therapies. With its market cap..

Claritev Corporation (CTEV) Stock Analysis: A Closer Look at its 3.97% Potential Upside

Claritev Corporation (CTEV), a prominent player in the healthcare sector, operates in the specialized niche of health information services. With a market capitalization of $1.12 billion, this New York-based company..

Community Health Systems, Inc. (CYH) Stock Analysis: Exploring a 33% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, specifically within the medical care facilities industry, has been navigating a challenging market environment. With a current..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking a 171.74% Potential Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, Nuvation Bio Inc. (NUVB) presents a compelling opportunity. Headquartered in New York, this clinical-stage biopharmaceutical company is making waves with..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 271% Potential Upside in the Biotech Sector

Investors looking for promising opportunities in the biotechnology sector may want to take a closer look at Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). This American biotech company, which focuses on pioneering..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 57.81% Potential Upside in the Health Information Services Sector

Weave Communications, Inc. (NYSE: WEAV), a prominent player in the health information services industry, is garnering attention from investors for its promising growth trajectory in the healthcare sector. Headquartered in..

Evolus, Inc. (EOLS) Stock Analysis: Aiming for a 196% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a notable player in the healthcare sector, is making waves in the drug manufacturing industry with its focus on specialty and generic products. Based in Newport..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds